Performance of chromosomal microarray for patients with intellectual disabilities/developmental delay, autism, and multiple congenital anomalies in a Chinese cohort

BACKGROUND: Chromosomal microarray (CMA) is currently the first-tier genetic test for patients with idiopathic neuropsychiatric diseases in many countries. Its improved diagnostic yield over karyotyping and other molecular testing facilitates the identification of the underlying causes of neuropsych...

Descripción completa

Detalles Bibliográficos
Autores principales: Chong, Wilson Wai Sing, Lo, Ivan Fai Man, Lam, Stephen Tak Sum, Wang, Chi Chiu, Luk, Ho Ming, Leung, Tak Yeung, Choy, Kwong Wai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055236/
https://www.ncbi.nlm.nih.gov/pubmed/24926319
http://dx.doi.org/10.1186/1755-8166-7-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055236/
https://www.ncbi.nlm.nih.gov/pubmed/24926319
http://dx.doi.org/10.1186/1755-8166-7-34

Ejemplares similares